+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Encephalomyelitis - Global Strategic Business Report - Product Thumbnail Image

Encephalomyelitis - Global Strategic Business Report

  • Report
  • February 2026
  • 380 Pages
  • Global
From
Albendazole Veterinary - Global Strategic Business Report - Product Thumbnail Image

Albendazole Veterinary - Global Strategic Business Report

  • Report
  • February 2026
  • 383 Pages
  • Global
From
Asthma Drugs - Global Strategic Business Report - Product Thumbnail Image

Asthma Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 177 Pages
  • Global
From
Basal Insulin - Global Strategic Business Report - Product Thumbnail Image

Basal Insulin - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
Human Recombinant Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Recombinant Insulin - Global Strategic Business Report

  • Report
  • February 2026
  • 189 Pages
  • Global
From
Nucleic Acid Based Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Based Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 291 Pages
  • Global
From
From
From
Budesonide Inhalers - Global Strategic Business Report - Product Thumbnail Image

Budesonide Inhalers - Global Strategic Business Report

  • Report
  • February 2026
  • 553 Pages
  • Global
From
Neurofibromatosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurofibromatosis Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 280 Pages
  • Global
From
Polypill Products - Global Strategic Business Report - Product Thumbnail Image

Polypill Products - Global Strategic Business Report

  • Report
  • February 2026
  • 378 Pages
  • Global
From
From
From
Sarcopenia Treatment - Global Strategic Business Report - Product Thumbnail Image

Sarcopenia Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 277 Pages
  • Global
From
Gallbladder Treatment - Global Strategic Business Report - Product Thumbnail Image

Gallbladder Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 472 Pages
  • Global
From
Sulfonylureas - Global Strategic Business Report - Product Thumbnail Image

Sulfonylureas - Global Strategic Business Report

  • Report
  • February 2026
  • 362 Pages
  • Global
From
Ketoconazole - Global Strategic Business Report - Product Thumbnail Image

Ketoconazole - Global Strategic Business Report

  • Report
  • February 2026
  • 274 Pages
  • Global
From
Recombinant Coagulation Factors - Global Strategic Business Report - Product Thumbnail Image

Recombinant Coagulation Factors - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
Dementia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dementia Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 286 Pages
  • Global
From
Apixaban - Global Strategic Business Report - Product Thumbnail Image

Apixaban - Global Strategic Business Report

  • Report
  • February 2026
  • 282 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more